News Category
A modeling analysis presented at the American Heart Association's Hypertension Scientific Sessions 2026 estimates that improving high blood pressure t...
Flu infections are rising earlier than usual in the US, highlighting the need for robust diagnostic tools and timely vaccination.
Consultwebs is providing a $50 stipend and half-day paid time off to employees who get a mammogram in 2026, an initiative inspired by its client Davis...
Avident Health and Unite for HER have secured a quality improvement grant from Pfizer and NCCN to deploy a digital navigation platform that bridges co...
The American College of Radiology now recommends that all women receive a formal breast cancer risk assessment by age 25, a shift that could lead to e...
VERAXA Biotech (NASDAQ: VRXA) is implementing FDA-aligned New Approach Methodologies (NAMs) that could accelerate clinical advancement, cut costs and ...
Lantern Pharma secures Taiwan regulatory and IRB approvals to open Part 2 of its Phase 2 HARMONIC trial, potentially accelerating development of LP-30...
VERAXA Biotech's adoption of FDA-aligned New Approach Methodologies could significantly reduce animal testing and accelerate the development of its an...
Telomir Pharmaceuticals' $5.6 million PIPE financing, including a $1 million investment from John Paul DeJoria, will fund the clinical development of ...
A new study reveals that the skull contains lymph node-like structures that may serve as a local immune defense for the brain, opening potential new a...
Kairos Pharma reported positive interim Phase 2 data showing ENV-105 plus apalutamide significantly improved progression-free survival in metastatic c...
GeoVax will present its next-generation MVA-X single-dose vaccine and continuous cell-line manufacturing platform at World Vaccine Congress Europe 202...
The Hong Kong Convention and Exhibition Centre hosted 786 events and over 7.7 million visitors in FY 2025-2026, including 25 new exhibitions and confe...
NHS England's new rapid brain tumor test drastically reduces diagnosis time, potentially accelerating access to innovative treatments from companies l...
A new blood-based method for identifying cancer-specific proteins could eliminate the need for surgical tumor samples in developing personalized immun...
Mega Bee Rescues & Pest Control is rebranding its signature yellow bee to pink for October and donating 5% of its South Florida service revenue to bre...
The College of Optometrists forecasts that more than three million UK children will become short-sighted by age 18, highlighting the urgent need for e...
Blue Faery will host a free liver cancer education event in Chicago on October 24, 2026, aiming to improve outcomes through better awareness of preven...
A board-certified vascular surgeon is raising awareness that venous lake, a benign blue or purple bump on the lip, is treatable with laser therapy, pr...
Onco-Innovations advances its cancer drug candidate ONC010 toward clinical trials by completing API scale-up, securing financing, and strengthening it...
The release of billions of pounds of cancer-causing chemicals into the U.S. environment in 2020 underscores the urgent need for both regulatory action...
BIOT's non-exclusive appointment as CelSiege's representative for the IN01 cancer immunotherapy in Japan and China opens new business development oppo...
Nashville Concierge Medicine's new article explains how adult ADHD can disrupt sleep, leading to daytime impairment, and underscores the importance of...
VERAXA Biotech has moved its VXA-222 bispecific antibody-drug conjugate beyond discovery, reinforcing its oncology pipeline and intellectual property ...
Nutriband Inc. (NASDAQ: NTRB) announced that CEO Gareth Sheridan is featured in a new documentary by independent journalist Nick Shirley examining the...
The CDC's report of likely sustained Clade Ib mpox transmission in the U.S. highlights the need for vaccine preparedness and diversified supply, as Ge...
Novogenia AG's H1 2026 report shows a 7% revenue decline but growth in DNA analysis and personalized health, alongside strategic partnerships and cost...
Discovery of a key protein driving glioblastoma growth could lead to new treatments for the deadliest brain cancer, as companies like CNS Pharmaceutic...
TransCode Therapeutics announced updated Phase 1a data showing a 71.4% stable disease rate and a favorable safety profile for TTX-MC138 in advanced so...
Psychiatrist Dr. Amar Surdhar's support for the HAS Foundation highlights the critical need for interdisciplinary collaboration and philanthropic inve...
VERAXA Biotech shifts focus to oncology pipeline and industrial partnerships after Nasdaq listing, while Xlife Sciences reports portfolio progress and...
The growing complexity of cancer care, driven by personalized treatments and immunotherapies, is making patient journeys increasingly individualized a...
Creative Biolabs has expanded its antibody portfolio targeting HIV-1, HIV-2, and HTLV-1 proteins, providing researchers with new tools for virology, i...
Quantum BioPharma is developing Lucid-MS, a drug candidate that aims to inhibit demyelination in multiple sclerosis, addressing a significant unmet ne...
Kairos Pharma's upcoming presentation on KROS-101 at a leading drug discovery conference underscores the company's innovative strategy to overcome can...
A new international study finds that waist-to-height ratio, a tape-measure-based metric, reliably screens for pediatric metabolic dysfunction-associat...
VERAXA Biotech's NASDAQ debut and recent executive appointments position the company to accelerate development of its BiTAC platform, which uses an AN...
Quantum BioPharma is developing Lucid-MS to inhibit demyelination in multiple sclerosis, addressing a critical unmet need for treatments that can reve...
TransCode Therapeutics secures key patent allowances in Australia and Japan, expanding its intellectual property portfolio for RNA-based cancer treatm...
Lantern Pharma received a USPTO Notice of Allowance for a patent covering LP-284 in blood cancers, extending intellectual property protection into 204...
The American Heart Association and American Headache Society have co-funded an Innovative Project Award to investigate the link between migraines and ...
A new injectable nanodevice technology developed at the MIT Media Lab destroyed over half of malignant cells in patient-derived brain tumor samples th...
VERAXA Biotech's NASDAQ listing and progress with its BiTAC platform signal a new phase in its efforts to develop novel cancer therapies, with potenti...
GeoVax's enhanced MVA vaccine, MVA-X, provides durable single-dose protection against lethal Clade I mpox and other orthopoxviruses in preclinical mod...
Onco-Innovations is advancing its preclinical cancer candidate ONC010 toward first-in-human testing by aligning manufacturing, formulation, and regula...
Experts urge small cell lung cancer patients to ask about clinical trials at their first appointment, as emerging research expands treatment options a...
Accelerated biological aging is emerging as a key explanation for the increasing incidence of cancer in adults under 55, with implications for prevent...
VERAXA Biotech's appointment of Raju Willener as CFO brings over 30 years of capital markets expertise to advance its BiTAC oncology pipeline and pote...
